Definitive Contract 75N93021C00051
Award Date 9/16/21
Potential Completion Date 9/15/22
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94566, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health awarded Phoenix-Micron, Inc. a $122,100 firm fixed-price purchase order contract to provide unspecified goods or services in support of the agency's operations in Bethesda, Maryland. As a prime contractor, Phoenix-Micron will perform the entirety of the contract, which runs from September 2023 through September 2024. No additional details were provided regarding subcontractors or the underlying requirements. The award was...
- This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
- <p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
- This $300,000.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Avantgen Inc., a small biotechnology company based in San Diego, California. The contract is for the development of a rapid and point-of-care diagnostic kit for the detection of the hepatitis C virus. This award is part of NIAID's solicitation for...
- This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
- This is a $182,526.96 firm fixed price contract awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to Phoenix Biosystem, Inc., a small disadvantaged business, under the SBIR Program Phase I. The contract is for research and development related to drug dependency management support. The award has a set-aside designation for total small business. The contract was awarded on September 30, 2009 with an ultimate completion date of September 29, 2010.
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Pathovacs Inc., a small biotechnology company based in Ames, Iowa. The $393,833 firm-fixed-price contract supports the development of a prototype in vitro diagnostic device for qualitative screening of individuals for anti-hepatitis C virus (HCV) antibodies to determine HCV exposure. This aligns with the NCI's mission to...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Baebies, Inc., a Durham, North Carolina-based medical device manufacturer. The contract, valued at $1,799,981.00, is for the development of a point-of-care digital microfluidic platform to diagnose viremic hepatitis C infection and confirm cure following treatment. The contract is a...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
- Pacific Biosciences of California, Inc. was awarded a $119,127 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This multiple delivery order contract, set aside for total small businesses, will provide PacBio kits and reagents to support genomic research initiatives through September 2021. The original solicitation requested brand name only PacBio reagents to fulfill sequencing...